By Professor Nada Hamad

Journal articles

Tokaz MC; Baldomero H; Cowan AJ; Saber W; Greinix H; Koh MBC; Kröger N; Mohty M; Galeano S; Okamoto S; Chaudhri N; Karduss AJ; Ciceri F; Colturato VAR; Corbacioglu S; Elhaddad A; Force LM; Frutos C; León AGD; Hamad N; Hamerschlak N; He N; Ho A; Huang XJ; Jacobs B; Kim HJ; Iida M; Lehmann L; de Latour RP; Percival MEM; Perdomo M; Rasheed W; Schultz KR; Seber A; Ko BS; Simione AJ; Srivastava A; Szer J; Wood WA; Kodera Y; Nagler A; Snowden JA; Weisdorf D; Passweg J; Pasquini MC; Sureda A; Atsuta Y; Aljurf M; Niederwieser D, 2023, 'An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia', Transplantation and Cellular Therapy, 29, pp. 279 - 279.e10, http://dx.doi.org/10.1016/j.jtct.2022.12.013

Nguyen J; Wellard C; Chung E; Cheah CY; Dickinson M; Doo NW; Keane C; Talaulikar D; Berkahn L; Morgan S; Hamad N; Cochrane T; Johnston AM; Forsyth C; Opat S; Barraclough A; Mutsando H; Ratnasingam S; Giri P; Wood EM; McQuilten ZK; Hawkes EA, 2023, 'Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry', European Journal of Haematology, 110, pp. 386 - 395, http://dx.doi.org/10.1111/ejh.13915

Noyola-Pérez A; Gil-Flores L; Martínez-Espinosa HA; Ramos-Barrera E; Rodríguez-González V; Sung L; Guzman M; Hamad N; Colunga-Pedraza PR; Tarín-Arzaga L; Cantú-Rodríguez OG; Gutiérrez-Aguirre H; Jaime-Pérez JC; Gómez-Almaguer D; León AGD, 2023, 'Global representation among journal editors in haematology: are we diverse, equitable, and inclusive?', Lancet Haematology, 10, pp. e246 - e247, http://dx.doi.org/10.1016/S2352-3026(23)00069-8

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Withers B; Hamad N, 2023, 'Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care', Jnccn Journal of the National Comprehensive Cancer Network, 21, pp. 366 - 372, http://dx.doi.org/10.6004/jnccn.2022.7255

Othman J; Aarons D; Bajel A; Butler J; Doocey R; O'Brien T; Purtill D; Smith L; Wilcox L; Hamad N, 2023, 'Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies', Internal Medicine Journal, 53, pp. 323 - 329, http://dx.doi.org/10.1111/imj.15886

White J; Elemary M; Linn SM; Novitzky-Basso I; Culos S; Tan SK; Kelly K; Deotare U; Xenocostas A; Hamad N; Law A; Kumar R; Kim DDH, 2023, 'A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid Failure', Transplantation and Cellular Therapy, 29, pp. 120 - 120.e9, http://dx.doi.org/10.1016/j.jtct.2022.11.025

Hamad N, 2023, 'Structural racism in clinical research limits its validity and applicability', Lancet Haematology, 10, pp. e85 - e86, http://dx.doi.org/10.1016/S2352-3026(23)00001-7

Perram J; Purtill D; Bajel A; Butler J; O'Brien T; Teh B; Gilroy N; Ho PJ; Doocey R; Hills T; Perera T; Douglas G; Ramachandran S; Chee L; Trotman J; Weinkove R; Keogh S; Fraser C; Cochrane T; Watson AM; Diamond P; Latimer M; Irving I; Blyth E; Cheah C; Cole T; Milliken S; Yang H; Greenwood M; Bardy P; Kennedy G; Larsen S; Conyers R; Hamad N, 2023, 'Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell', Internal Medicine Journal, 53, pp. 119 - 125, http://dx.doi.org/10.1111/imj.15978

Baggio D; Wellard C; Chung E; Talaulikar D; Keane C; Opat S; Giri P; Minson A; Cheah CY; Armytage T; Lee D; Chong G; Johnston A; Cochrane T; Waters N; Hamad N; Wood EM; Hawkes EA, 2023, 'Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry', Leukemia and Lymphoma, 64, pp. 621 - 627, http://dx.doi.org/10.1080/10428194.2022.2157676

Mills GS; Di Ciaccio PR; Tang C; Chadwick V; Mason KD; Campbell BA; Shipton MJ; Shanavas M; Morris KL; Greenwood M; Langfield J; Kidson-Gerber G; Eslick R; Badoux X; Yannakou CK; Gangatharan SA; Bilmon I; Hamad N, 2023, 'Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study', Leukemia and Lymphoma, 64, pp. 319 - 328, http://dx.doi.org/10.1080/10428194.2022.2148376

Dickinson M; Hamad N; Bryant CE; Kothari N; Ojeras P; Vohra A; Lin M; Tohme M; Trager J; Shook D; Kennedy G; Tees M; Hill BT, 2023, 'First in human data of NKX019, an allogeneic CAR NK for the treatment of relapsed/refractory (R/R) B‐cell malignancies', Hematological Oncology, 41, pp. 526 - 527, http://dx.doi.org/10.1002/hon.3164_389

Minson A; Verner E; Giri P; Wong SM; Ratnasingam S; Butler J; Janowski W; Ku M; Cheah CY; Hertzberg M; Herbert K; Hamad N; Yannakou CK; Neeson P; Saghebi J; Blombery P; Robertson M; Lau LS; Xie J; Seymour JF; Dickinson M, 2023, 'Glofitamab plus R‐CHOP or polatuzumab vedotin‐R‐CHP is deliverable with high overall response in patients ≤65 years of age with high‐risk DLBCL: Interim analysis of COALITION', Hematological Oncology, 41, pp. 421 - 422, http://dx.doi.org/10.1002/hon.3164_309

Shaw B; Chung E; Wellard C; Yoo E; Bennett R; Birks C; Johnston A; Cheah C; Hamad N; Simpson J; Barraclough A; Ku M; Viiala N; Ratnasingam S; Armytage T; Cochrane T; Chong G; Lee D; Manos K; Keane C; Wallwork S; Opat S; Hawkes E, 2023, 'POLATUZUMAB, BENDAMUSTINE & RITUXIMAB EFFICACY IN RELAPSED/REFRACTORY TRIAL‐INELIGIBLE LARGE B CELL LYMPHOMA PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY', Hematological Oncology, 41, pp. 718 - 719, http://dx.doi.org/10.1002/hon.3165_572

Body A; Donoghoe MW; Ahern ES; Lal L; Downie P; Leahy MF; Fuentes-Bolanos N; Anazodo A; Padhye B; Hamad N; Wakefield CE; Segelov E, 2023, 'Safety and patient reported outcomes of SARS-CoV-2 vaccination in patients with cancer', ANNALS OF ONCOLOGY, 34, pp. S1104 - S1104, http://dx.doi.org/10.1016/j.annonc.2023.09.888

Anderson MA; Berkahn L; Cheah C; Dickinson M; Gandhi MK; Giri P; Hawkes EA; Johnston A; Keane C; McQuilten ZK; Mulligan SP; Opat S; Talaulikar D; Trotman J; Williams J; Wood EM; Armytage T; Barraclough A; Carradice D; Chong G; Cochrane T; Hamad N; Ku M; Lee D; Morgan S; Mutsando H; Narayana M; Prince HM; Ratnasingam S; Wight J; Badoux X; Cull G; Kuss B; Marlton P; Tam C; Casan J; Cushion T; Tedjaseputra A; Birch S; Brown C; Ellis D; Harvey Y; Hitchins S; Jain S; Jessup P; Juneja S; Kearney D; Kumar B; Lade S; Lee K; Leslie C; Long E; Morey A; Nath L; Norris D; Parker A; Parry J; Chen FPY; Chung E; Morison J; Rowsell L; St George G; Thu C; Waters N; Wellard C; Zheng M, 2022, 'Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry', BMC Medical Research Methodology, 22, http://dx.doi.org/10.1186/s12874-022-01728-0

Tokaz M; Baldomero H; Cowan AJ; Saber W; Greinix HT; Koh M; Kröger N; Mohty M; Galeano S; Okamoto S; Chaudhri NA; Karduss AJ; Ciceri F; Colturato VR; Corbacioglu S; Elhaddad AM; Force L; Frutos Ortiz CA; Gomez-De Leon A; Hamad N; Hamerschlak N; He N; Ho AYL; Huang X-J; Jacobs B; Kim H; Iida M; Lehmann LE; Peffault de Latour R; Percival M-EM; Rasheed W; Schultz KR; Seber A; Ko B-S; Simione A; Srivastava A; Szer J; Wood WA; Kodera Y; Nagler A; Snowden JA; Weisdorf DJ; Passweg JR; Pasquini MC; Sureda A; Atsuta Y; Aljurf M; Niederwieser D; Perdomo M, 2022, 'An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia', Blood, 140, pp. 8146 - 8149, http://dx.doi.org/10.1182/blood-2022-158338

Goh Z; Latimer M; Lewis KL; Cheah CY; Di Ciaccio P; Cushion T; Hawkes E; Harrop S; Ku M; Campbell A; Hamad N; Wood EM; Chung E; Chen P-Y; Cochrane T, 2022, 'Characteristics and Outcomes of Elderly Patients with Classical Hodgkin Lymphoma (cHL): An Australian Lymphoma Alliance (ALA), and Lymphoma and Related Disease Registry (LaRDR) Study', Blood, 140, pp. 9413 - 9415, http://dx.doi.org/10.1182/blood-2022-156782

Sutrave G; Indran T; Jivan Y; Hutchison A; Hamad N; Tan S; Purtill D; Grigg A; Tey S-K; Curtis DJ; Gottlieb DJ; Bhattacharyya A, 2022, 'Ibrutinib for Steroid Refractory Chronic Graft Vs Host Disease - Real World Experience', Blood, 140, pp. 10537 - 10539, http://dx.doi.org/10.1182/blood-2022-168683

Minson A; Hamad N; Cheah CY; Tam CS; Blombery P; Westerman DA; Lade S; Ritchie D; Koldej RM; Anderson MA; Khot A; Seymour JF; Robertson M; Caldwell IR; Ryland GL; Xie J; Morgan H; Dickinson M, 2022, 'Time-Limited Ibrutinib and Tisagenlecleucel Is Highly Effective in the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma, Including Those with TP53 Mutated and Btki-Refractory Disease: First Report of the Tarmac Study', Blood, 140, pp. 181 - 183, http://dx.doi.org/10.1182/blood-2022-160459

Body A; Ahern ES; Lal L; Abdulla H; Opat S; Downie P; Leahy M; Fuentes-Bolanos N; Padhye B; Hamad N; Milch V; Segelov E, 2022, 'Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response', ANNALS OF ONCOLOGY, 33, pp. 1544 - 1544, http://dx.doi.org/10.1016/j.annonc.2022.10.312

Perram J; Ross DM; McLornan D; Gowin K; Kröger N; Gupta V; Lewis C; Gagelmann N; Hamad N, 2022, 'Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis', American Journal of Hematology, 97, pp. 1464 - 1477, http://dx.doi.org/10.1002/ajh.26654

Brennan X; Withers B; Jabbour A; Milliken S; Kotlyar E; Fay K; Ma D; Muthiah K; Hamad N; Dodds A; Bart N; Keogh A; Hayward C; Macdonald P; Moore J, 2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926

Segelov E; Body A; Lal L; Abdulla H; Turville S; Naing Z; Opat S; Leahy M; Balendra JR; Hamad N; Mccuaig R; Rao S; Lineburg K; Smith C; MacIntyre CR; Milch V; Busija L; Ahern ES, 2022, 'Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer', ANNALS OF ONCOLOGY, 33, pp. S1279 - S1279, http://dx.doi.org/10.1016/j.annonc.2022.07.1704

Bain N; Nguyen M; Grech L; Day D; McCartney A; Webber K; Kwok A; Harris S; Chau H; Chan B; Nott L; Hamad N; Tognela A; Underhill C; Loe BS; Freeman D; Segelov E, 2022, 'COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers', Vaccines, 10, http://dx.doi.org/10.3390/vaccines10091373

Keane C; Hamad N; Barraclough A; Lee YY; Talaulikar D; Ku M; Wight J; Tatarczuch M; Swain F; Gregory GP, 2022, 'Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance', Internal Medicine Journal, 52, pp. 1624 - 1632, http://dx.doi.org/10.1111/imj.15658

Wight J; Hamad N; Campbell BA; Ku M; Lee K; Rose H; Armytage T; Latimer M; Lee HP; Lee ST; Dickinson M; Khor R; Verner E, 2022, 'Diffuse large B-cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance', Internal Medicine Journal, 52, pp. 1609 - 1623, http://dx.doi.org/10.1111/imj.15533

Schuster M; Zijlstra J; Casasnovas RO; Vermaat JSP; Kalakonda N; Goy A; Choquet S; Neste EVD; Hill B; Thieblemont C; Cavallo F; De la Cruz F; Kuruvilla J; Hamad N; Jaeger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Follows G; Egyed M; Offner F; Vassilakopoulos T; Samal P; Ku M; Ma X; Corona K; Chamoun K; Shah J; Shacham S; Kauffman MG; Canales M; Maerevoet M, 2022, 'Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study', Clinical Lymphoma Myeloma and Leukemia, 22, pp. 483 - 494, http://dx.doi.org/10.1016/j.clml.2021.12.016

Perram J; Schoemans H; Hamad N, 2022, 'First, do no harm: the neglect of female genital disease following haematopoietic stem-cell transplantation', Lancet Haematology, 9, pp. e476 - e477, http://dx.doi.org/10.1016/S2352-3026(22)00186-7

Chai KL; Wellard C; Aoki N; Moore EM; Augustson B; Bapat A; Blacklock HA; Chng WJ; Cooke R; Forsyth C; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge IH; Kim JS; Kim K; King T; McCaughan GJ; Mollee P; Morrissey CO; Murphy N; Quach H; Tan XN; Tso A; Wong K; Spencer A; Wood EM; McQuilten ZK, 2022, 'P1573: VARIATION IN USE OF IMMUNOGLOBULIN AND IMPACT ON SURVIVAL IN MULTIPLE MYELOMA: A REPORT FROM THE AUSTRALIA/NEW ZEALAND (ANZ) AND ASIA-PACIFIC (APAC) MYELOMA AND RELATED DISEASES REGISTRIES (MRDR)', HemaSphere, 6, pp. 1454 - 1455, http://dx.doi.org/10.1097/01.hs9.0000849148.93868.54

Connolly EA; Weickhardt A; Grimison P; Asher R; Heller GZ; Lewin J; Liow E; Toner G; Tung ILY; Tran B; Hill S; Walpole E; McKenzie J; Kuchel A; Goh J; Forgeson G; Tan A; Joshi A; Wickham A; Tan H; Wang Y; Winstanley MA; Hamad N; Wong V, 2022, 'High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres', BJU International, 130, pp. 5 - 16, http://dx.doi.org/10.1111/bju.15648

Enjeti AK; Agarwal R; Blombery P; Chee L; Chua CC; Grigg A; Hamad N; Iland H; Lane S; Perkins A; Singhal D; Tate C; Tiong IS; Ross DM, 2022, 'Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement', Pathology, 54, pp. 389 - 398, http://dx.doi.org/10.1016/j.pathol.2022.03.002

Day D; Grech L; Nguyen M; Bain N; Kwok A; Harris S; Chau H; Chan B; Blennerhassett R; Nott L; Hamad N; Tognela A; Hoffman D; McCartney A; Webber K; Wong J; Underhill C; Sillars B; Winkel A; Savage M; Loe BS; Freeman D; Segelov E, 2022, 'Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia', Vaccines, 10, http://dx.doi.org/10.3390/vaccines10060851

Kliman D; Tran S; Kennedy G; Curley C; McLean A; Gottlieb D; Kwan J; Ritchie D; Chee L; Spencer A; Purtill D; Bardy P; Larsen S; Chien N; Perera T; Greenwood M; Hamad N; Moore J, 2022, 'The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR', Bone Marrow Transplantation, 57, pp. 982 - 989, http://dx.doi.org/10.1038/s41409-022-01683-w

Niederwieser D; Baldomero H; Bazuaye N; Bupp C; Chaudhri N; Corbacioglu S; Elhaddad A; Frutos C; Galeano S; Hamad N; Hamidieh AA; Hashmi S; Ho A; Horowitz MM; Iida M; Jaimovich G; Karduss A; Kodera Y; Kröger N; de Latour RP; Lee JW; Martínez-Rolón J; Pasquini MC; Passweg J; Paulson K; Seber A; Snowden JA; Srivastava A; Szer J; Weisdorf D; Worel N; Koh MBC; Aljurf M; Greinix H; Atsuta Y; Saber W, 2022, 'One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors', Haematologica, 107, pp. 1045 - 1053, http://dx.doi.org/10.3324/haematol.2021.279189

Cashman H; Sushil S; Mayson E; Milliken S; Lavee O; Awford A; Hamad N, 2022, 'Telemedicine for rural and regional patient access to haematology services during the COVID-19 pandemic in Australia', Lancet Haematology, 9, pp. e325 - e326, http://dx.doi.org/10.1016/S2352-3026(22)00110-7

Wilson MR; Eyre TA; Kirkwood AA; Wong Doo N; Soussain C; Choquet S; Martinez-Calle N; Preston G; Ahearne M; Schorb E; Moles-Moreau MP; Ku M; Rusconi C; Khwaja J; Narkhede M; Lewis KL; Calimeri T; Durot E; Renaud L; Øvlisen AK; McIlroy G; Ebsworth TJ; Elliot J; Santarsieri A; Ricard L; Shah N; Liu Q; Zayac AS; Vassallo F; Lebras L; Roulin L; Lombion N; Manos K; Fernandez R; Hamad N; Lopez-Garcia A; O'Mahony D; Gounder P; Forgeard N; Lees C; Agbetiafa K; Strüßmann T; Htut TW; Clavert A; Scott H; Guidetti A; Barlow BR; Tchernonog E; Smith J; Miall F; Fox CP; Cheah CY; El Galaly TC; Ferreri AJM; Cwynarski K; McKay P, 2022, 'Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients', Blood, 139, pp. 2499 - 2511, http://dx.doi.org/10.1182/blood.2021014506

Tang C; King K; Ross B; Hamad N, 2022, 'Iron deficiency in women: clearing the rust of silence', Lancet Haematology, 9, pp. e247 - e248, http://dx.doi.org/10.1016/S2352-3026(22)00079-5

Perram J; Hamad N, 2022, 'Not all mismatches are equal: importance of alloreactivity direction', Haematologica, 107, pp. 787 - 789, http://dx.doi.org/10.3324/haematol.2021.279587

Montoto S; Snowden JA; Chabannon C; Corbacioglu S; de la Camara R; Dolstra H; Greco R; Gusi A; Hamad N; Kenyon M; Kröger N; Mohty M; Murray J; Mueller A; Neven B; Peffault de Latour R; Peric Z; Sánchez-Ortega I; Sureda A; Verhoeven B; Villar A; Yakoub-Agha I, 2022, 'The first steps towards a diverse and inclusive EBMT: a position paper', Bone Marrow Transplantation, 57, pp. 343 - 346, http://dx.doi.org/10.1038/s41409-022-01586-w

Bishop MR; Dickinson M; Purtill D; Barba P; Santoro A; Hamad N; Kato K; Sureda A; Greil R; Thieblemont C; Morschhauser F; Janz M; Flinn I; Rabitsch W; Kwong YL; Kersten MJ; Minnema MC; Holte H; Chan EHL; Martinez-Lopez J; Müller AMS; Maziarz RT; McGuirk JP; Bachy E; Gouill SL; Dreyling M; Harigae H; Bond D; Andreadis C; McSweeney P; Kharfan-Dabaja M; Newsome S; Degtyarev E; Awasthi R; Del Corral C; Andreola G; Masood A; Schuster SJ; Jäger U; Borchmann P; Westin JR, 2022, 'Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma', New England Journal of Medicine, 386, pp. 629 - 639, http://dx.doi.org/10.1056/NEJMoa2116596

Zijlstra JM; Follows G; Casasnovas RO; Vermaat JSP; Kalakonda N; Choquet S; Hill B; Thieblemont C; Cavallo F; De la Cruz F; Kuruvilla J; Hamad N; Jaeger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Xu J; Corona K; Chamoun K; Shah J; Canales M; Maerevoet M, 2022, 'The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study', Cancers, 14, http://dx.doi.org/10.3390/cancers14030791

Casasnovas RO; Follows G; Zijlstra JM; Vermaat JSP; Kalakonda N; Choquet S; Neste EVD; Hill B; Thieblemont C; Cavallo F; la Cruz FD; Kuruvilla J; Hamad N; Jaeger U; Caimi PF; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Ma X; Chamoun K; Shah J; Canales M; Maerevoet M; Shacham S; Kauffman MG; Goy A, 2022, 'Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes', Clinical Lymphoma Myeloma and Leukemia, 22, pp. 24 - 33, http://dx.doi.org/10.1016/j.clml.2021.07.017

Nivison-Smith I; Bajel A; Dodds AJ; Gottlieb D; Hamad N; Kennedy G; Kerridge I; Ma DDF; Milliken S; Moore J; Purtill D; Szer J, 2022, 'Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience', Internal Medicine Journal, 52, pp. 57 - 62, http://dx.doi.org/10.1111/imj.15128

Mills G; Anderson MA; Tang C; Hamad N, 2022, 'The untold effect of the combined oral contraceptive pill on anticancer drugs', Lancet Haematology, 9, pp. e10 - e11, http://dx.doi.org/10.1016/S2352-3026(21)00377-X

Harrop S; Di Ciaccio P; Doo NW; Cochrane T; Campbell BA; Hamad N; Dickinson M; Van Der Weyden C; Prince HM, 2022, 'The gamma delta lymphomas: an Australian multi-centre case series', Annals of Lymphoma, 6, pp. 3 - 3, http://dx.doi.org/10.21037/aol-21-41

Bishop MR; Dickinson M; Purtill D; Barba P; Santoro A; Hamad N; Kato K; Sureda A; Greil R; Thieblemont C; Morschhauser F; Janz M; Flinn IW; Rabitsch W; Kwong YL; Kersten MJ; Minnema MC; Holte H; Chan EHL; Martinez-Lopez J; Mueller AMS; Maziarz RT; McGuirk JP; Bachy E; Le Gouill S; Dreyling M; Harigae H; Bond DA; Andreadis C; McSweeney PA; Kharfan-Dabaja MA; Newsome S; Degtyarev E; Del Corral C; Andreola G; Masood A; Schuster SJ; Jaeger U; Borchmann P; Westin JR, 2021, 'Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-155068

Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N, 2021, 'Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic', Transplantation and Cellular Therapy, 27, pp. 1022 - 1022.e6, http://dx.doi.org/10.1016/j.jtct.2021.09.012

Maerevoet M; Zijlstra JM; Follows G; Casasnovas RO; Vermaat JSP; Kalakonda N; Goy A; Choquet S; Van Den Neste E; Hill B; Thieblemont C; Cavallo F; De la Cruz F; Kuruvilla J; Hamad N; Jaeger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Ma X; Corona K; Chamoun K; Shah J; Shacham S; Kauffman MG; Canales M, 2021, 'Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study', Journal of Hematology and Oncology, 14, http://dx.doi.org/10.1186/s13045-021-01122-1

Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-154028

Farooq F; Cardonick E; Polushkina E; Ahmed S; Ramakrishnan P; Olszewski AJ; Yasin H; Hamad N; Lin Y; Edmonds J; Ciavolino L; Maggen C; Fruscio R; Gziri MM; Steffensen KD; Farooq U; Amant F; Sharon E; Yin T; Figg WD; Brandt J; Peer C; Vose JM; Evens AM, 2021, 'A Multi-Institution Analysis of Relapsed Lymphoma Occurring during Pregnancy Including Pharmacokinetics with Antenatal Checkpoint Inhibitor Therapy', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-149220

Back to profile page